Pathogenic protozoa are distributed in the natural environment and various hosts, and have unique biological characteristics, life cycle and specific value as living organisms. Pathogenic protozoa are important biological resources as bioecological mediator with lot of genetic information and are causative agents of all organisms including humans. The goals of the Material Resource Bank of Parasitic Protozoa Pathogen are DB construction of pathogens and derivatives, promotion of research activities through distribution, and prevention of the waste of resources.
The blood of infected patients is difficult to collect for individual researchers. Human Serum Bank collects samples of high-risk viral antigens and antibodies. Typical high risk viruses include HBV, HCV, HIV, and HTLV. Collected samples are provided to researchers or industries in accordance with the regulations and the guidelines for blood serum banks.
The development of a more effective, targeted treatment for gynecologic cancer depends on an increased understanding of the molecular mechanisms involved during the initiation of a tumor, and its progression to metastatic disease and resistance to treatment.
Human biospecimens, such as tissue, blood, urine, peritoneal fluid, and saliva, have emerged as a critical resource for basic and translational research in gynecologic cancer because they are direct sourcesof molecular data from which targets for therapy, detection, and prevention can be identified. Research studies heavily depend on the availability of high quality biological material from patients with gynecologic cancer.
As a result of an increased requirement for biospecimen quality, standardization of biospecimen resources using state-of-the-art approaches has become valuable across the research enterprise.
Korea International Biobank for Infectious Diseases
The goals of Korea International Biobank for Infectious Diseases (KOIBID) are as follows;
1) Collection of human-origin samples of overseas infectious diseases, which are difficult to collect in Korea, using international network of KOICID (Korea International Cooperation for Infectious Diseases) at Inje University,
2) Control of human-origin samples that include those of infectious diseases named Biosafety level 2, such as malaria, dengue fever, zika virus infection, in a high quality,
3) Sharing human-origin samples with researchers,
4) Development of diagnostic techniques, treatment agents and preventive vaccines,
5) Protection from threats of overseas infectious diseases to our nation
With the changing of lifestyle, the prostate disease has been increasing steadily. The Korea Prostate Bank (KPB) has a network of 16 hospitals, 3 institutions, a pharmaceutical company, and a bio venture business. KPB holds specimens from patients with prostate cancer and BPH (Benign Prostatic Hypertrophy). All the specimens are barcoded to protect personal information and to manage specimens efficiently. The goals of KPB are to provide human specimens (tissue, blood, serum and urine) as well as derivatives (DNA, RNA and proteins) for prostate research and to establish a database system (bioinformatics) which can support clinical trials and basic research data about prostate diseases.
Korean Cell Line Bank (KCLB) was established in 1987 as a cell culture collection and has been playing a role as a nonprofit bioscience organization aimed for distributing the essential cell lines to the life science researchers. On August 31, 1993, Korean Cell Line Research Foundation (KCLRF) acquired the status of ‘the International Depositary Authority (IDA)’ approved by the World Intellectual Property Organization (WIPO) as specified in article 6 of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the purpose of patent procedure.
The cause and progression of liver cancer is extremely diverse. Thus, for any basic and translational study of liver cancer, there is the need to use patient-derived specimens and clinical information to identify genetic changes involved in the development and progression of liver cancer and to apply the best diagnostic as well as therapeutic methods. The goal of the Liver Cancer Specimen Bank (LCSB) is to support and stimulate research on liver cancer and metastatic liver cancer. LCSB aims to increase the diagnosis and treatment rates by providing various specimens donated from patients and sharing research resources, information, and results among researchers.
The Korea Leukemia Bank (KLB) was established in 2002 and has been developing diagnostic methods and characterizing leukemia cells. Aims of the KLB are; 1) To establish and manage synthetic leukemia cells 2) To develop new diagnostic methods to acquire the basic and distinctive information of leukemic cells collected from Korean population 3) To increase competitiveness of researches on multiple leukemia and cancer. KLB has constructed a database of information and systematic management of leukemia cell lines.
Korea Lung Tissue Bank
2002 ~ 2012
Korea University
In post-genome era, the human tissue is an essential material for bioresearch, early detection of disease and the development of new pharmaceuticals. Korea Lung Tissue Bank (KLTB) is supporting researchers in ‘translational research’ and ‘personalized medicine’ by providing biospecimens for research and dealing with common ethical, legal, scientific and technical issues regarding human specimen banking. KLTB collects human bio-specimen as well as the donor’s clinical information. Also, KLTB provides molecular information obtained by genetic and proteomic analysis.
> RRCs > RRCs
Global Resource of Parasitic Protozoa Pathogen
2016 ~ Now
Inha University
http://grbppp.knrrc.or.kr
Korea Leukemia Bank
